NCT03169855

Brief Summary

A) The main purposes of this study are (i) to develop a related virtual reality (VR) environment in order to judge the nighttime driving ability under mesopic and under glare conditions (ophthalmologically healthy subjects and patients with incipient to intermediate cataract, i.e. opacities of the human lens, will participate in this study), (ii) to validate the above-mentioned VR environment with respect to a related on-road driving scenario under mesopic and glare conditions, (iii) to validate clinical photopic and mesopic contrast vision tests and glare tests with respect to the prediction of nighttime driving ability, (iv) to assess the test retest reliability of clinical photopic and mesopic contrast vision tests B) Background: An intact mesopic vision and a glare sensitivity within a normal range are essential pre-requisites for safe driving at nighttime (DOG \& BVA, 2011). Anderson \& Holiday (1995) have shown that (simulated) opacities of the refractive media (with only minor effects on daytime visual acuity) induce a pronounced impairment of contrast sensitivity under nighttime conditions. Especially under glare conditions by the headlights of traffic on the opposite lane or by stationary street illumination, an impairment of the mesopic vision may cause traffic hazards. The prevalence of impairments of the central visual acuity, the mesopic vision and the glare sensitivity is significantly higher for subjects being involved in nighttime traffic accidents (Lachenmayr, 1998). Furthermore, these impairments occur more frequently in aged drivers and are, among others, related to an increase of age-related media opacities (Aulhorn \& Harms, 1970, Babizhayev, 2003). Due to the demographic change, the relevance of nighttime driving ability is increasing in the next years since more and more aged employees will participate at the motorized traffic at night. The German Fahrerlaubnisverordnung (FEV i.e. driving license regulation) specifies pass/fail criteria with regard to mesopic vision and glare sensitivity. The luminance level during nighttime driving is usually between 0.01 and 1 cd/m\^2, and therefore can be attributed to the level of mesopic vision. However, over the last years, the attempt was made to introduce photopic contrast sensitivity test to diagnose nighttime driving ability (i.e. testing of contrast vision under daytime conditions without time consuming adaptation procedures). Current research aims at investigating the relationship between contrast tests under various luminance conditions (Wilhelm et al, 2013). It is questionable, whether photopic tests are at all reliable predictors with regard to nighttime driving (Gramberg-Danielsen et al., 1984, Hertenstein et al., Graefe´s Archive of Ophthalmology, 2016).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
54

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started May 2017

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 2, 2017

Completed
17 days until next milestone

First Submitted

Initial submission to the registry

May 19, 2017

Completed
11 days until next milestone

First Posted

Study publicly available on registry

May 30, 2017

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2018

Completed
Last Updated

January 10, 2019

Status Verified

January 1, 2019

Enrollment Period

1.7 years

First QC Date

May 19, 2017

Last Update Submit

January 8, 2019

Conditions

Keywords

Traffic OphthalmologyGlareCataractNighttime drivingcontrast sensitivitymesopic vision

Outcome Measures

Primary Outcomes (1)

  • Pass/fail rate (i.e. ratio of "no. of subjects passed" by "total no. of participants") with respect to a vision-related driving ability test

    Pass/fail rates will be assessed for vision related driving ability tests: (i) clinical photopic/mesopic contrast vision tests, (ii) glare tests, (iii) of driving simulator tests under mesopic conditions with and without glare, and (iv) on-road tests under mesopic conditions with and without glare

    From date of "first subject in" to date of "last subject out", i.e. over an 18 months period

Secondary Outcomes (4)

  • Rank of tested subjects with respect to a vision-related driving ability test

    From date of "first subject in" to date of "last subject out", i.e. over an 18 months period

  • Test-retest reliability, expressed as "limits of agreement" (LOA) of a clinical contrast vision test

    From date of "first subject in" to date of "last subject out", i.e. over an 18 months period

  • Response time (in milliseconds) regarding to the gap recognition of a standardized optotype

    From date of "first subject in" to date of "last subject out", i.e. over an 18 months period

  • Intensity of driving simulator sickness, assessed by a questionnaire

    From date of "first subject in" to date of "last subject out", i.e. over an 18 months period

Study Arms (2)

Refractive media opacities: present

Refractive media opacities: present

Refractive media opacities: absent

Refractive media opacities: absent

Diagnostic Test: Slit lamp (LOCS III Score)

Interventions

Diagnostic procedure only

Also known as: Oculus Pentacam (Scheimpflug procedure, densitometry)
Refractive media opacities: absent

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Ophthalmologically healthy subjects and patients with incipient to intermediate cataract.

You may qualify if:

  • age ≥ 18 years (preferred: age, exceeding 50 yrs.)
  • Minimum distant visual acuity (with habitual correction) 0.8 (16/20, single optotypes, LANDOLT C chart for presentation of high contrast optotypes according to DIN 58220 - Part 3/ISO 10938 (Visus GmbH, Stuttgart/Germany)
  • ametropia maximum spherical ametropia sph ±8.00 dpt maximum maximum astigmatism cyl 2.00 dpt
  • normal (age-corrected) visual field
  • clear refractive media OR incipient to intermediate cataract
  • informed consent

You may not qualify if:

  • epilepsy / psychiatric disorders
  • drugs, interfering with reaction time and/or with visual acuity or with refractive status of the eye
  • deficient driving license
  • yearly mileage less than 3000 km/y (less than 1.864 miles/y)
  • amblyopia
  • strabismus
  • ocular motility disorders
  • nystagmus
  • double vision
  • albinism
  • glaucoma / IOP exceeding 22 mmHg
  • shallow anterior chamber/risk of angle closure glaucoma (van HERICK grade less than 2)
  • macular diseases / maculopathy
  • diabetic retinopathy (blood sugar-related retinal disease)
  • status post severe eye injuries
  • +5 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Applied Sciences, Study Course Ophthalmic Optics

Aalen, Baden-Wurttemberg, 73430, Germany

Location

MeSH Terms

Conditions

CataractVision Disorders

Interventions

Slit Lamp Microscopy

Condition Hierarchy (Ancestors)

Lens DiseasesEye DiseasesSensation DisordersNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Diagnostic Techniques, OphthalmologicalDiagnostic Techniques and ProceduresDiagnosis

Study Officials

  • Ulrich Schiefer, Prof. Dr.

    Aalen University of Applied Sciences

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 19, 2017

First Posted

May 30, 2017

Study Start

May 2, 2017

Primary Completion

December 31, 2018

Study Completion

December 31, 2018

Last Updated

January 10, 2019

Record last verified: 2019-01

Data Sharing

IPD Sharing
Will not share

Locations